A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fasting Conditions.
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2010
At a glance
- Drugs Valaciclovir (Primary)
- Indications Cytomegalovirus infections; Herpes simplex virus infections; Herpes zoster; Herpesvirus infections
- Focus Pharmacokinetics
- 09 Jun 2010 According to a Roxane Laboratories Inc media release, the US Food and Drug Administration has approved the Abbreviated New Drug Application (ANDA) of Valacyclovir Hydrochloride Tablets 500mg and 1g.
- 01 Jun 2010 New trial record